Technology
Health
Pharmaceutical

Krystal Biotech

$51.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.89 (3.83%) Today
$0.00 (0.00%) As of 4:29 PM EDT after-hours

Why Robinhood?

You can buy or sell KRYS and other stocks, options, ETFs, and crypto commission-free!

About KRYS

Krystal Biotech, Inc. Common Stock, also called Krystal Biotech, is a gene therapy company, which engages in developing and commercializing treatment for patients suffering from dermatological diseases. Read More It developed a gene therapy platform, which company refer to as the Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases for which company believe there are no known effective treatments. The company was founded by Suma M. Krishnan in December 2017 and is headquartered in Pittsburgh, PA.

Employees
37
Headquarters
Pittsburgh, Pennsylvania
Founded
2015
Market Cap
713.66M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
177.50K
High Today
$51.40
Low Today
$48.65
Open Price
$49.55
Volume
147.68K
52 Week High
$51.40
52 Week Low
$14.30

Collections

Technology
Health
Pharmaceutical
Therapy
2017 IPO
US
North America

KRYS News

Yahoo FinanceJun 24

Why NRC Group Holdings, PCM, and Krystal Biotech Jumped Today

999
MarketWatchJun 24

Krystal Biotech shares up 27% after company's skin drug receives expedited review designation from FDA

549

KRYS Earnings

-$0.48
-$0.39
-$0.30
-$0.21
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 5, Pre-Market

More KRYS News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.